- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04012515
CAVA: Electrode Pad Appraisal Trial (CEPAT)
Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Electrode Pad Appraisal Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dizziness is a common condition that is responsible for a significant degree of material morbidity and burden on our health service. There are multiple causes of dizziness, and these originate from pathologies affecting a large variety of different organ systems. Dizziness is usually episodic and short-lived, so when a patient presents to their health care provider, examination is often normal. As such, diagnosis is challenging and patients often experience significant delay in receiving a diagnosis. We have developed a device for monitoring dizziness and in 2018 we evaluated the device by undertaking a clinical trial involving healthy volunteers. Following the promising results from the first trial, we will conduct a second trial in 2019 on patients suffering from dizziness.
During the healthy volunteer trial, a minor issue was encountered relating to long-term daily wear of the device's electrode pads. Specifically, nine participants reported varying degrees of skin redness and inflammation beneath their electrode pads, mostly occurring after around two weeks of wear. The issue was self-limiting and resolved after a few days of non-wear. The team worked closely with a consultant dermatologist in order to monitor and manage this adverse event.
Since the issue was identified, the team has consulted with a number of people with relevant expertise in order to determine the causes of the issue and to find the most viable solution. Based on these discussions, we propose that the causes of this issue were due to a combination of wear duration, and/or repeated removal, and/or the specific type of electrode pad used. To confidently identify the cause of this issue and to evaluate a number of possible solutions, we intend to undertake a trial to evaluate the tolerability of alternative electrode pads and different patterns of wear.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Norwich, United Kingdom, NR7 7UY
- Norfolk & Norwich University Hospitals NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults aged 18 and over.
- Able to commit to 30 days of continuous wear of the electrode pads as per the study plan.
- Own a telephone.
Exclusion Criteria:
- Potential participants who have a history of dermatological disease, damage around the forehead, or fragile skin.
- Potential participants who have an allergy to plasters and/or medical adhesives.
- Potential participants who have taken part in a previous CAVA trial.
- Potential participants who are currently taking part in another trial.
- Unable to follow the testing protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CAVA Electrode Pad Appraisal Trial Arm
All trial participants are within this arm.
All participants will wear the same selection of electrode pads and follow the same replacement schedules.
|
Participants wear six electrode pads in total; three different types of pad, worn in the same positions on both sides of the face.
The pads on the left-hand side of the face are replaced daily, and those on the right-hand side are replaced every other day.
The pads do not administer a medical treatment or perform any other active function.
The purpose of the intervention is to determine which combination of pad and replacement regime maximises the tolerability of wear over a 30-day period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The maximum duration of comfortable wear of electrode pad
Time Frame: 1 month
|
The maximum duration of comfortable wear will be calculated for each combination of electrode pad and wear regime, and the longest duration will determine the best electrode pad for use with the CAVA device.
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John Phillips, Consultant ENT Surgeon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 261103 (25-02-19)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tolerability of Wear of Electrode Pads
-
MerLion Pharmaceuticals GmbHCompletedPharmacokinetic and Tolerability of FinafloxacinUnited States
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Reinier Haga Orthopedisch CentrumRecruitingWear of Articular Bearing Surface of Prosthetic Joint | Migration of ImplantNetherlands
-
Cairo UniversityUnknown
-
University of British ColumbiaCompletedEfficacy of Bowel Preparation | Ease of Bowel Preparation and Patient TolerabilityCanada
-
Chattem, Inc.CompletedTolerability | Adhesiveness | Dermal Irritation | Effects of HeatUnited States
-
Shanghai Junshi Bioscience Co., Ltd.UnknownTolerability, Safety, Immunogenicity and Pharmacokinetic of JS005China
-
Chattem, Inc.CompletedTolerability | Adhesiveness | Dermal Irritation | Effects of HeatUnited States
-
Mansoura UniversityCompletedOcclusal Wear of TeethEgypt
-
Avidhrt Inc.Michigan State University; ASCENSION SACRED HEART; Spring Arbor UniversityNot yet recruitingEquivalence of ECG Electrode Type Signal Quality for AF and Non AF Users
Clinical Trials on Electrode Pads
-
Central Taiwan University of Science and TechnologyRecruiting
-
Essity Hygiene and Health ABCompleted
-
Chang Gung UniversityHung Kaung UniversityCompletedAnalgesia | Transcutaneous Electrical Nerve Stimulation | Blunt Pressure Pain | Pad Size | Pulse FrequencyTaiwan
-
Mahidol UniversityCompletedPain | Delirium | Agitation on Recovery From SedationThailand
-
East Carolina UniversityTerminated
-
ConvaTec Inc.Unknown
-
Hacettepe UniversityCompletedInner Ear Malformations
-
RetMap, IncUniversity of Illinois at Chicago; Illinois College of OptometryActive, not recruitingElectrode Site ReactionUnited States
-
Stanford UniversityCompleted
-
Mayo ClinicUniversity of MinnesotaWithdrawn